NSAIDs Modulate Clonal Evolution in Barrett's Esophagus

Cancer is considered an outcome of decades-long clonal evolution fueled by acquisition of somatic genomic abnormalities (SGAs). Non-steroidal anti-inflammatory drugs (NSAIDs) have been shown to reduce cancer risk, including risk of progression from Barrett's esophagus (BE) to esophageal adenoca...

Descripción completa

Detalles Bibliográficos
Autores principales: Kostadinov, Rumen L., Kuhner, Mary K., Li, Xiaohong, Sanchez, Carissa A., Galipeau, Patricia C., Paulson, Thomas G., Sather, Cassandra L., Srivastava, Amitabh, Odze, Robert D., Blount, Patricia L., Vaughan, Thomas L., Reid, Brian J., Maley, Carlo C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681672/
https://www.ncbi.nlm.nih.gov/pubmed/23785299
http://dx.doi.org/10.1371/journal.pgen.1003553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681672/
https://www.ncbi.nlm.nih.gov/pubmed/23785299
http://dx.doi.org/10.1371/journal.pgen.1003553

Ejemplares similares